These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26852184)

  • 1. Successful rapid subcutaneous desensitization to anakinra in a case of delayed-type hypersensitivity reaction.
    Leroy V; Lazaro E; Darrigade AS; Taïeb A; Milpied B; Seneschal J
    Br J Dermatol; 2016 Jun; 174(6):1417-8. PubMed ID: 26852184
    [No Abstract]   [Full Text] [Related]  

  • 2. Continuation of anakinra despite the development of a pruritic rash in an otherwise refractory case of adult-onset Still's disease.
    Vordenbäumen S; Ostendorf B; Sander O; Richter J; Schneider M
    Ann Rheum Dis; 2009 Mar; 68(3):450-1. PubMed ID: 19213754
    [No Abstract]   [Full Text] [Related]  

  • 3. Cutaneous delayed hypersensitivity from anakinra - The importance of clinical suspicion and skin testing.
    Alen Coutinho I; Saraiva AP; Cunha F; Luís M; Todo Bom A
    Contact Dermatitis; 2021 Sep; 85(3):381-382. PubMed ID: 33861883
    [No Abstract]   [Full Text] [Related]  

  • 4. [Severe hepatitis in a patient with adult-onset Still's disease treated with anakinra].
    Diallo A; Mekinian A; Boukari L; Mouas H; Zamy M; Nahon P; Gérin M; Fain O
    Rev Med Interne; 2013 Mar; 34(3):168-70. PubMed ID: 23182291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two cases of anakinra-induced neutropenia during auto-inflammatory diseases: drug reintroduction can be successful.
    Perrin F; Néel A; Graveleau J; Ruellan AL; Masseau A; Hamidou M
    Presse Med; 2014 Mar; 43(3):319-21. PubMed ID: 24456697
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiac death in a patient with adult-onset Still's disease treated with the interleukin 1 receptor inhibitor anakinra.
    Ruiz PJ; Masliah E; Doherty TA; Quach A; Firestein GS
    Ann Rheum Dis; 2007 Mar; 66(3):422-3. PubMed ID: 17179171
    [No Abstract]   [Full Text] [Related]  

  • 7. Is exogenous administration of IL-1ra (anakinra) likely to induce severe depression?
    Jonville-Bera AP; Guilmot JL; Aspe G; Autret-Leca E; Magnant J
    Eur J Clin Pharmacol; 2011 Feb; 67(2):213-4. PubMed ID: 20941485
    [No Abstract]   [Full Text] [Related]  

  • 8. Severe systemic inflammatory response syndrome in a patient with adult onset Still's disease treated with the anti-IL1 drug anakinra: a case report.
    Guignard S; Dien G; Dougados M
    Clin Exp Rheumatol; 2007; 25(5):758-9. PubMed ID: 18078628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of anakinra in a case of refractory Still disease.
    Debiais S; Maillot F; Luca L; Buret J; Fautrel B; Renard JP
    J Clin Rheumatol; 2008 Dec; 14(6):357-8. PubMed ID: 19033875
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiac magnetic resonance in myocarditis from adult onset Still's disease successfully treated with anakinra.
    Choi AD; Moles V; Fuisz A; Weissman G
    Int J Cardiol; 2014; 172(1):e225-7. PubMed ID: 24461482
    [No Abstract]   [Full Text] [Related]  

  • 11. Subacute liver failure following anakinra treatment for adult-onset Still disease.
    Aly L; Iking-Konert C; Quaas A; Benten D
    J Rheumatol; 2013 Oct; 40(10):1775-7. PubMed ID: 24085761
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of refractory adult onset Still's disease with combination anakinra and baricitinib therapy.
    Ladhari C; Jorgensen C; Pers YM
    Rheumatology (Oxford); 2019 Apr; 58(4):736-737. PubMed ID: 30590753
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term efficacy and safety of Anakinra in a patient with liver transplant due to Adult onset Still's Disease.
    Yilmaz S; Cinar M; Simsek I; Erdem H; Pay S
    Mod Rheumatol; 2014 Nov; 24(6):1030-1. PubMed ID: 24313885
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and long-term follow-up of IL-1R inhibitor anakinra in adults with Still's disease: a case-series study.
    Laskari K; Tzioufas AG; Moutsopoulos HM
    Arthritis Res Ther; 2011 Jun; 13(3):R91. PubMed ID: 21682863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anakinra in children and adults with Still's disease.
    Vastert SJ; Jamilloux Y; Quartier P; Ohlman S; Osterling Koskinen L; Kullenberg T; Franck-Larsson K; Fautrel B; de Benedetti F
    Rheumatology (Oxford); 2019 Nov; 58(Suppl 6):vi9-vi22. PubMed ID: 31769856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anakinra treatment in patients with adult-onset Still's disease is fast, effective, safe and steroid sparing: experience from an uncontrolled trial.
    Kalliolias GD; Georgiou PE; Antonopoulos IA; Andonopoulos AP; Liossis SN
    Ann Rheum Dis; 2007 Jun; 66(6):842-3. PubMed ID: 17513574
    [No Abstract]   [Full Text] [Related]  

  • 17. Anakinra for the treatment of adult-onset Still's disease.
    Castañeda S; Atienza-Mateo B; Martín-Varillas JL; Serra López-Matencio JM; González-Gay MA
    Expert Rev Clin Immunol; 2018 Dec; 14(12):979-992. PubMed ID: 30324816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients' experience and tolerability with canakinumab and anakinra for the treatment of adult-onset Still's disease.
    Campochiaro C; Farina N; Tomelleri A; De Luca G; Cavalli G; Dagna L
    Clin Exp Rheumatol; 2022 Sep; 40(8):1598-1599. PubMed ID: 35349406
    [No Abstract]   [Full Text] [Related]  

  • 19. Adult-onset Still's disease in a patient with cystic fibrosis and its successful treatment with anakinra.
    Albersmeyer MP; Hilge RG; Schulze-Koops H; Sitter T
    Rheumatology (Oxford); 2012 Sep; 51(9):1730-2. PubMed ID: 22513144
    [No Abstract]   [Full Text] [Related]  

  • 20. Effective treatment of steroid refractory adult-onset Still's disease with anakinra.
    Maier J; Birkenfeld G; Pfirstinger J; Schölmerich J; Fleck M; Brühl H
    J Rheumatol; 2008 May; 35(5):939-41. PubMed ID: 18464320
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.